Published within
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
...
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
Report
|
The biologic drug market is growing at nearly twice the pace of the overall pharma market. This report forecasts microbial and mammalian contract manufacturing markets to 2017. Market dynamics and leading players are also examined.
Published By Datamonitor
|
19 Feb 2013 |
$2800
|
Case Studies
|
The pharmaceuticals market is currently in the middle of a "patent cliff." This case study looks at the various routes companies are taking in order to minimize the adverse effects caused by the patent cliff.
Published By MarketLine
|
08 Jun 2012 |
$495
|
Report
|
Comparative efficacy data are not necessarily required for approval but are increasingly demanded by payers. Meeting the expectations of all stakeholders can be challenging, making comparator selection and trial design complex decisions.
Published By Datamonitor
|
23 Aug 2012 |
$2800
|
Report
|
High Phase II attrition is hampering the pharma industry’s ability to reach sustainable rates of innovation. More rigorous validation of new biological targets prior to clinical development is essential for increasing R&D efficiency.
Published By Datamonitor
|
28 Sep 2012 |
$2800
|
Report
|
This report explores key issues in dengue, Japanese encephalitis and West Nile infection. It contains an analysis of epidemiological trends, assessment of marketed vaccines and discusses the pipeline for vaccines and virus-specific therapeutics.
Published By Datamonitor
|
14 Dec 2010 |
$2800
|
Order this report by October 22nd 2010 and receive a 30% discount
To take advantage of this offer enter Promo Code TBI30 when prompted in the checkout
More information
|
Report
|
Analysis of traumatic brain injury epidemiology, unmet needs and pipeline treatments. Provides analysis of opportunities and threats facing developers of TBI treatments based on interviews with six key opinion leaders.
Published By Datamonitor
|
07 Apr 2010 |
$3800
|
Report
|
This report assesses the current landscape of and future opportunities for therapeutic vaccines outside cancer, covering therapeutic vaccine approaches in cardiovascular and metabolic, CNS, autoimmune and infectious diseases.
Published By Datamonitor
|
17 Dec 2009 |
$3800
|
Report
|
Assessment of the potential impact of agents targeting nerve growth factor (NGF) for the treatment of pain. Includes analysis of the key market drivers and resistors for this new class based on interviews with key opinion leaders.
Published By Datamonitor
|
05 Mar 2010 |
$3800
|
Report
|
Analysis of spinal cord injury epidemiology, unmet needs and pipeline treatments. Provides assessment of potential market value and analysis of opportunities and threats facing developers of SCI treatments based on interviews with key opinion leaders
Published By Datamonitor
|
05 Mar 2010 |
$3800
|
Report
|
This report gives a comprehensive overview of trends in epidemiology, diagnosis, treatment and referral patterns for skin and soft tissue infections (SSTIs). It discusses the challenges, opportunities and future developments for the SSTI drug market.
Published By Datamonitor
|
16 Jul 2009 |
$3800
|
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
...
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.